New Delhi: The AIIMS started clinical trials of Covaxin for children from Monday in New Delhi. The AIIMS started clinical trials of the Covid – 19 vaccines to see if it is suitable for children between the age group two and 18 years.

The third wave of Covid – 19 will affect more on children. The third wave of Covid – 19 will bring as much devastation as the second wave of the Covid – 19 pandemic if enough people are not vaccinated against the virus, said the experts. Covaxin, Covishield and Sputnik V vaccines have not been approved for use on children in India. The Centre had given its clearance to the clinical trials on May 13.

Several States have started preparations for the anticipated third wave. They are now focusing on creating healthcare infrastructure for children. Many States have also announced special Pediatric Intensive Care Units.